2D AND 3D IMAGING SYSTEM FOR A CUTANEOUS PIGMENT DISORDER
20220015639 · 2022-01-20
Inventors
Cpc classification
A61B5/0077
HUMAN NECESSITIES
A61B5/0073
HUMAN NECESSITIES
A61B5/444
HUMAN NECESSITIES
A61B5/6898
HUMAN NECESSITIES
A61B5/0075
HUMAN NECESSITIES
G06T11/006
PHYSICS
International classification
Abstract
An imaging system for a cutaneous pigment disorder which includes a device for acquiring 2D images of the pigment disorder, comprising: a light source comprising at least one emitter and receivers, a unit for processing the 2D images acquired, means for displaying the images processed. The invention further comprises: means for positioning the receivers at at least two viewing angles, which positioning means are distributed along a spherical cap, a structure for protecting the acquisition device and an operator, comprising a receiver-positioning opening, the protection structure being intended to be positioned on the skin. The processing unit comprises a 3D reconstruction module with a reflective Radon transform in order to obtain a 3D image which is reconstructed from the 2D images processed and the display means further comprise means for displaying the reconstructed 3D image.
Claims
1. An imaging system for a cutaneous pigment disorder which comprises: a device (A) for acquiring 2D images of the pigment disorder comprising: a light source configured to illuminate said disorder comprising at least one emitter and receivers, a unit (B) for processing the acquired 2D images (S1), in order to obtain processed 2D images (S2), means (D1) for visualizing the processed images (S2), further comprising: means for positioning the receivers at at least two viewing angles so as to obtain at least one image per viewing angle, which means are distributed over a spherical cap, a structure for protecting the acquisition device (A) and an operator, comprising a window for positioning the receivers so as to direct them toward the pigment disorder, the protective structure being intended to be positioned on the skin and having an external surface that is opacified except for over the positioning window, in that the processing unit (B) comprises a module for 3D reconstruction using reflection Radon transform so as to obtain a 3D image (S3) reconstructed on the basis of the processed 2D images (S2), and in that the visualization means further comprise means (D2) for visualizing the reconstructed 3D image (S3).
2. The imaging system for a cutaneous pigment disorder as claimed in claim 1, wherein the protective structure has dimensions compatible with a portable acquisition device (A).
3. The imaging system for a cutaneous pigment disorder as claimed in claim 1, wherein the acquisition device (A) comprises a multicellular structure, each cell containing a receiver.
4. The imaging system for a cutaneous pigment disorder as claimed in claim 3, wherein each cell comprises an emitter-receiver.
5. The imaging system for a cutaneous pigment disorder as claimed in claim 4, wherein for each image capture, the emitting angle and the receiving angle are oriented and equal with respect to the normal to the plane containing the skin.
6. The imaging system for a cutaneous pigment disorder as claimed in claim 3, wherein the acquisition device comprises a light source emitting in the visible band and means for acquiring the images (S1) simultaneously via the receivers.
7. The imaging system for a cutaneous pigment disorder as claimed in claim 1, wherein the positioning means comprise a rail on which one or more receivers are positioned and means for rotating the rail.
8. The imaging system for a cutaneous pigment disorder as claimed in claim 7, wherein the acquisition device comprises a single receiver or a single emitter-receiver on the rail and in that the rail is a sliding rail.
9. The imaging system for a cutaneous pigment disorder as claimed in claim 1, wherein the light source is multiwavelength in the visible and near-infrared bands, and/or the band of the first therapeutic window and/or the band of the second therapeutic window and/or the SWIR band, the one or more receivers corresponding to said wavelengths and being synchronized with the emitters, and in that the acquisition device comprises means for acquiring the images (S1) successively via the receivers at a rate of at least one image per wavelength and per viewing angle.
10. The imaging system for a cutaneous pigment disorder as claimed in claim 1, wherein the positioning window is arranged at the apex of the protective structure (1).
11. The imaging system for a cutaneous pigment disorder as claimed in claim 1, wherein the positioning window features a magnifying glass.
12. The imaging system for a cutaneous pigment disorder as claimed in claim 1, wherein it is portable.
13. The imaging system for a cutaneous pigment disorder as claimed in claim 1, wherein the acquisition device (A) is integrated into a mobile telephone.
Description
[0043] Other features and advantages of the invention will become apparent from reading the following detailed description, given by way of non-limiting example and with reference to the appended drawings, in which:
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056] From one figure to another, the same elements bear the same references.
[0057] According to the invention, the imaging system for pigment disorders described with reference to
[0058] A device A for acquiring 2D images at various viewing angles and potentially at various wavelengths for each viewing angle, which generates raw 2D images S1 and the associated data (viewing angles and wavelength).
[0059] An image processing unit B which generates processed 2D images S2 from the raw images S1 and the associated data and which preferably also generates a 3D reconstruction S3 of the pigment disorder and of its roots on the basis of the processed images S2.
[0060] Means D1 for 2D visualization, at various viewing angles, of the pigment disorder on the basis of the processed 2D images S2.
[0061] Means D2 for 3D visualization of the pigment disorder and of its reconstructed roots S3.
[0062] The image processing unit B and/or the visualization means D1 and D2 may be remote from the acquisition device A.
[0063] The image processing unit B performs RAW conversions to an usable image format (JPEG, PNG, TIFF, etc.), corrections for optical aberrations, framing, centering, registration, calibration, scaling, thresholding, and angular indexing of the raw images S1. Processed images S2 are obtained. Examples of processed 2D images S2 of a nevus at various viewing angles (20°, 30°, . . . , 160°, 170°) are given in
[0064] Preferably, as shown in
[0065] These images S3 are of point-cloud, isodensity, voxel-rendering type (for example maximum intensity projection (MIP), as described in patent EP 3 234 914 B1: Method for discrimination and identification of objects of a scene by 3D imaging. The MIP technique makes it possible to visualize three-dimensional data in a two-dimensional plane. The voxels (volume pixels) are projected onto a 2D plane; the voxels are determined by the rays meeting the projection plane at the observation point and applying an imposed intensity threshold to the voxels. A plurality of projection planes are created at successive observation angles in order to obtain an impression of depth and thus improve the 3D rendering. An illustration of a rendering of the voxels of the reconstructed 3D volume (S3) of a nevus is given in
[0066] The 2D (images S2) and 3D (images S3) visualization means D1 and D2 are typically PCs, tablets, mobile telephones (“smartphones”) or any other visualization means.
[0067] The device A for acquiring 2D images, at various viewing angles, of the pigment disorder, shown in
[0068] a light source configured to illuminate the pigment disorder. It comprises one or more emitters oriented toward the pigment disorder 60 (an example of which is shown in
[0069] one or more receivers 303 (shown in
[0070] It is possible to have devices referred to as emitter-receivers 3 integrating the emitting function and the receiving function within the same device as shown in
[0071] means for positioning the one or more receivers (or even also the one or more emitters) at M viewing angles (M≥2) with respect to the pigment disorder which are distributed over a spherical cap as can be seen in
[0072] According to one embodiment, the acquisition device comprises a multicellular structure, each cell 6 containing a receiver, or an emitter-receiver 3. This structure takes the shape of the spherical cap as shown in
[0073] The acquisition device may be adapted from or integrated into a mobile telephone (smartphone).
[0074] the acquisition device further comprises a structure 1 for protecting the operator 50 and the emitters and receivers, which generally follows the shape of the positioning means as shown in the figures, but other shapes may be envisaged (cubic, or compound or other). This structure 1 comprises a window for positioning the acquisition device so as to direct it toward the disorder 60. The positioning window is arranged at the apex of the protective structure 1, on the normal to the disorder 60 along the axis z (the skin is in a plane xy). Thus, the operator may position, by way of direct visual inspection, the acquisition device so that the window faces the disorder 60, as illustrated in
[0075]
[0076] Preferably, the dimensions of the structure 1 are compatible with a portable acquisition device A which is easy to place on various parts of the body: when the structure 1 forms for example a dome as shown in the figures, it typically has a radius of <15 cm. The structure may also be fixed and of larger dimensions.
[0077] By way of non-limiting example, the interfacing (35) is of the type: memory card slot, USB, Wi-Fi, Bluetooth, etc.
[0078] Two image acquisition techniques may be used: [0079] “Passive” imaging technique: it concerns the visible and near-infrared bands. The pigment disorder is illuminated by the ambient light from outside the device passing through the positioning window, potentially equipped with the magnifying glass 4, which remains transparent to the ambient light. The emitter in question is then the ambient light. The 2D images are acquired successively for the device described with reference to
[0080] “Active” imaging technique: it concerns the visible and infrared bands. The pigment disorder is illuminated by the emitting sources 301, 302 of the emitter-receivers 3, the positioning window no longer being transparent to the ambient light from outside the device; this window is for example masked by the operator or may also be equipped with a shutter as indicated above. Illumination may be performed successively in a plurality of wavelengths for each viewing angle. The pigment disorder is then imaged successively for each wavelength and for each viewing angle. The acquisition device then comprises means for successive acquisition which are synchronized with the illuminations, such as means for synchronizing the receivers with the emitters. This technique makes it possible to obtain a 3D image of the surface volume of the disorder and a deep three-dimensional imaging of the pigment disorder. Advantageously, for each image capture, the emitting angle and the receiving angle are oriented and equal, or near-equal, with respect to the normal to the plane containing the skin. These angles (θ, φ) are illustrated in
[0081] The invention makes it possible to obtain a three-dimensional volume image by way of illumination in the “first therapeutic window” (650 nm-950 nm); this approach results in increased spatial resolution and minimized background noise The use of three-dimensional imaging, the spectroscopic properties (photon absorption and emission) of which lie within the first therapeutic window, allows access to the imaging of “thick” tissues.
[0082] The “second therapeutic window” (1000 nm-1350 nm) makes it possible to increase the depth of penetration of the wave due to the minimization of photon scattering, and it is thus possible to obtain light transmission over several millimeters in depth. This emission window provides additional information on the evolution of the roots of the nevus and its microvascularization.
[0083] The scattering of the light wave from the various wavelengths used allows an array of three-dimensional reconstructions of pigment disorders and therefore complete and comparative information on pigment disorders given that the effects of scattering of light waves from pigment disorders are complementary (depth of scattering, scattering cross section, determination of the roughness of the scattering structure) according to the illumination wavelengths used.
[0084] Thus, the obtained two-dimensional images are used to obtain a three-dimensional reconstruction of the skin at depth, in particular for those illumination wavelengths having a high penetrating power with respect the tissues of the skin.
[0085] This 2D and 3D imaging system applies mainly to the biomedical field, to the identification of cutaneous or subcutaneous disorders. In the context of non-melanoma skin cancers (basal-cell carcinoma, squamous-cell carcinoma for example), the system according to the invention allows precise visualization of the three-dimensional limits of the tumor, which makes it possible to be certain of the complete exeresis of a malignant skin tumor which is a condition for healing.
[0086] Thus, the most frequent simple nodular forms (45 to 60% of cases) are very clearly delimited, but within these simple forms there may be a micronodular form, without peripheral delimitation and requiring greater margins of exeresis, the three-dimensional image allowing precise representation of these complex shapes.
[0087] Thus, the three-dimensional imaging makes it possible to reveal structures and signs that are invisible to the naked eye, improving the performance of the clinical diagnosis of pigmented lesions, to detect three-dimensional parameters allowing the differential diagnosis between melanomas, carcinomas and nevi to be refined (localization, shape, depth, highlighting of vascularization around the melanoma/carcinoma, changes to microrelief, changes to the dermoepidermal junction, vascular changes, visualization of the limits of the tumor which makes it possible to be certain of the complete exeresis of a skin tumor).